[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 58,333
Sort by:

2019 Meconium Aspiration Syndrome (MAS) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Meconium Aspiration Syndrome (MAS) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Meconium Aspiration Syndrome (MAS). It presents in-depth analysis of Meconium Aspiration Syndrome (MAS) clinical trials ...

April 2019 38 pages

2019 Medullary Thyroid Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Medullary Thyroid Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Medullary Thyroid Cancer. It presents in-depth analysis of Medullary Thyroid Cancer clinical trials ...

April 2019 98 pages

2019 Melasma (Chlosma) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Melasma (Chlosma) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Melasma (Chlosma). It presents in-depth analysis of Melasma (Chlosma) clinical trials across markets and companies ...

April 2019 59 pages

2019 Membranous Glomerulonephritis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Membranous Glomerulonephritis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Membranous Glomerulonephritis. It presents in-depth analysis of Membranous Glomerulonephritis clinical trials across markets and companies ...

April 2019 71 pages

2019 Memory Impairment Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Memory Impairment Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Memory Impairment. It presents in-depth analysis of Memory Impairment clinical trials across markets and companies ...

April 2019 100 pages

2019 Meniere Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Meniere Disease Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Meniere Disease. It presents in-depth analysis of Meniere Disease clinical trials across markets and companies ...

April 2019 60 pages

2019 Meningioma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Meningioma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Meningioma. It presents in-depth analysis of Meningioma clinical trials across markets and companies ...

April 2019 94 pages

2019 Meningitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Meningitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Meningitis. It presents in-depth analysis of Meningitis clinical trials across markets and companies ...

April 2019 210 pages

2019 Menopausal Disorders Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Menopausal Disorders Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Menopausal Disorders. It presents in-depth analysis of Menopausal Disorders clinical trials across markets and companies ...

April 2019 320 pages

2019 Menorrhagia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Menorrhagia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Menorrhagia. It presents in-depth analysis of Menorrhagia clinical trials across markets and companies ...

April 2019 102 pages

2019 Metabolic Acidosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Metabolic Acidosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Metabolic Acidosis. It presents in-depth analysis of Metabolic Acidosis clinical trials across markets and companies ...

April 2019 112 pages

2019 Metachromatic Leukodystrophy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Metachromatic Leukodystrophy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Metachromatic Leukodystrophy. It presents in-depth analysis of Metachromatic Leukodystrophy clinical trials across markets and companies ...

April 2019 42 pages

2019 Metastatic Brain Tumor Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Metastatic Brain Tumor Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Metastatic Brain Tumor. It presents in-depth analysis of Metastatic Brain Tumor clinical trials ...

April 2019 272 pages

2019 Metastatic Hepatocellular Carcinoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Metastatic Hepatocellular Carcinoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Metastatic Hepatocellular Carcinoma. It presents in-depth analysis of Metastatic Hepatocellular Carcinoma clinical trials ...

April 2019 74 pages

2019 Metastatic Hormone Refractory Prostate Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... - “2019 Metastatic Hormone Refractory Prostate Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Metastatic Hormone Refractory Prostate Cancer. It presents in-depth analysis of Metastatic Hormone Refractory Prostate Cancer ...

April 2019 464 pages

2019 Metastatic Ovarian Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Metastatic Ovarian Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Metastatic Ovarian Cancer. It presents in-depth analysis of Metastatic Ovarian Cancer clinical trials ...

April 2019 155 pages

2019 Metastatic Transitional (Urothelial) Tract Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... - “2019 Metastatic Transitional (Urothelial) Tract Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Metastatic Transitional (Urothelial) Tract Cancer. It presents in-depth analysis of Metastatic Transitional (Urothelial) Tract Cancer ...

April 2019 158 pages

2019 Metastatic Uveal Melanoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Metastatic Uveal Melanoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Metastatic Uveal Melanoma. It presents in-depth analysis of Metastatic Uveal Melanoma clinical trials ...

April 2019 66 pages

2019 Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... - “2019 Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. It presents in-depth analysis of Methicillin-Resistant Staphylococcus aureus (MRSA ...

April 2019 118 pages

2019 Metrorrhagia (Abnormal Uterine Bleeding) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Metrorrhagia (Abnormal Uterine Bleeding) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Metrorrhagia (Abnormal Uterine Bleeding). It presents in-depth analysis of Metrorrhagia (Abnormal Uterine Bleeding) clinical trials ...

April 2019 54 pages

2019 Microalbuminuria Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Microalbuminuria Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Microalbuminuria. It presents in-depth analysis of Microalbuminuria clinical trials across markets and companies ...

April 2019 58 pages

2019 Microscopic Polyangiitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Microscopic Polyangiitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Microscopic Polyangiitis. It presents in-depth analysis of Microscopic Polyangiitis clinical trials across markets and companies ...

April 2019 55 pages

2019 Mild Cognitive Impairment Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Mild Cognitive Impairment Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mild Cognitive Impairment. It presents in-depth analysis of Mild Cognitive Impairment clinical trials ...

April 2019 288 pages

2019 Milk Allergy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Milk Allergy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Milk Allergy. It presents in-depth analysis of Milk Allergy clinical trials across markets and companies ...

April 2019 64 pages

2019 Mineral Deficiency Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Mineral Deficiency Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mineral Deficiency. It presents in-depth analysis of Mineral Deficiency clinical trials across markets and companies ...

April 2019 78 pages

2019 Mitral Regurgitation Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Mitral Regurgitation Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mitral Regurgitation. It presents in-depth analysis of Mitral Regurgitation clinical trials across markets and companies ...

April 2019 42 pages

2019 Mitral Valve Diseases Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Mitral Valve Diseases Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mitral Valve Diseases. It presents in-depth analysis of Mitral Valve Diseases clinical trials ...

April 2019 57 pages

2019 Mixed Dyslipidemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Mixed Dyslipidemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mixed Dyslipidemia. It presents in-depth analysis of Mixed Dyslipidemia clinical trials across markets and companies ...

April 2019 69 pages

2019 Muckle-Wells Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Muckle-Wells Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muckle-Wells Syndrome. It presents in-depth analysis of Muckle-Wells Syndrome clinical trials across markets and companies ...

April 2019 41 pages

2019 Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... trial report- “2019 Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ...

April 2019 55 pages

2019 Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... trial report- “2019 Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ...

April 2019 55 pages

2019 Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... trial report- “2019 Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ...

April 2019 51 pages

2019 Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome ) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... trial report- “2019 Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome ) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome ...

April 2019 46 pages

2019 Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... trial report- “2019 Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mucopolysaccharidosis VI (MPS VI) (Maroteaux ...

April 2019 41 pages

2019 Mucositis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Mucositis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mucositis. It presents in-depth analysis of Mucositis clinical trials across markets and companies ...

April 2019 184 pages

2019 Mumps Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Mumps Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mumps. It presents in-depth analysis of Mumps clinical trials across markets and companies ...

April 2019 65 pages

2019 Muscle Atrophy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Muscle Atrophy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscle Atrophy. It presents in-depth analysis of Muscle Atrophy clinical trials across markets and companies ...

April 2019 185 pages

2019 Muscle Injury Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Muscle Injury Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscle Injury. It presents in-depth analysis of Muscle Injury clinical trials across markets and companies ...

April 2019 105 pages

2019 Muscle Invasive Bladder Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Muscle Invasive Bladder Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscle Invasive Bladder Cancer. It presents in-depth analysis of Muscle Invasive Bladder Cancer clinical trials ...

April 2019 105 pages

2019 Muscle Relaxation Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Muscle Relaxation Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscle Relaxation. It presents in-depth analysis of Muscle Relaxation clinical trials across markets and companies ...

April 2019 81 pages

2019 Muscle Spasm Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Muscle Spasm Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscle Spasm. It presents in-depth analysis of Muscle Spasm clinical trials across markets and companies ...

April 2019 171 pages

2019 Muscle Spasticity Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Muscle Spasticity Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscle Spasticity. It presents in-depth analysis of Muscle Spasticity clinical trials across markets and companies ...

April 2019 210 pages

2019 Muscle Wasting Disorders Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Muscle Wasting Disorders Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscle Wasting Disorders. It presents in-depth analysis of Muscle Wasting Disorders clinical trials ...

April 2019 182 pages

2019 Muscular Dystrophy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Muscular Dystrophy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscular Dystrophy. It presents in-depth analysis of Muscular Dystrophy clinical trials across markets and companies ...

April 2019 197 pages

2019 Myalgia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Myalgia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myalgia. It presents in-depth analysis of Myalgia clinical trials across markets and companies ...

April 2019 122 pages

2019 Myasthenia Gravis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Myasthenia Gravis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myasthenia Gravis. It presents in-depth analysis of Myasthenia Gravis clinical trials across markets and companies ...

April 2019 66 pages

2019 Mycobacterium avium Intracellulare Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Mycobacterium avium Intracellulare Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mycobacterium avium Intracellulare Infections. It presents in-depth analysis of Mycobacterium avium Intracellulare Infections clinical trials ...

April 2019 44 pages

2019 Mycoplasma pneumoniae Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Mycoplasma pneumoniae Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mycoplasma pneumoniae Infections. It presents in-depth analysis of Mycoplasma pneumoniae Infections clinical trials ...

April 2019 42 pages

2019 Mycosis Fungoides Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Mycosis Fungoides Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mycosis Fungoides. It presents in-depth analysis of Mycosis Fungoides clinical trials across markets and companies ...

April 2019 141 pages

2019 Myelofibrosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Myelofibrosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myelofibrosis. It presents in-depth analysis of Myelofibrosis clinical trials across markets and companies ...

April 2019 238 pages

Filters

Search

Categories

60
12,968
1,223
4,429
2
1
10,890
2,818
15,138
67
8,921
1
1,229
586

Publishers

58,333

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
58,296

Price

Date

Pages

Offers